HomeSANA • NASDAQ
add
Sana Biotechnology Inc
Previous close
$4.30
Day range
$3.93 - $4.24
Year range
$1.26 - $7.30
Market cap
1.08B USD
Avg Volume
4.58M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 45.51M | -26.04% |
Net income | -42.15M | 29.66% |
Net profit margin | — | — |
Earnings per share | -0.15 | 44.44% |
EBITDA | -42.32M | 26.37% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 153.05M | -23.09% |
Total assets | 435.43M | -22.16% |
Total liabilities | 240.12M | -10.04% |
Total equity | 195.31M | — |
Shares outstanding | 266.37M | — |
Price to book | 5.81 | — |
Return on assets | -28.55% | — |
Return on capital | -46.14% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -42.15M | 29.66% |
Cash from operations | -29.43M | 43.21% |
Cash from investing | -48.02M | -214.96% |
Cash from financing | 109.54M | 5,161.29% |
Net change in cash | 32.09M | 502.99% |
Free cash flow | -17.56M | 43.97% |
About
CEO
Founded
2018
Headquarters
Website
Employees
194
